Amersham plc acquires Pharmacia Corp.’s stake in Amersham Biosciences, taking Amersham’s ownership from 55 per cent to 100 per cent.

Complete ownership brings the businesses under the Amersham brand and helps the company pursue its strategy of enabling molecular medicine through global leadership in medical diagnostics and life sciences.